Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.
Effect of immunosuppressive cladribine treatment on serum leucocytes system in two-year clinical trial in patients with chronic progressive multiple sclerosis.
Natalizumab Use During the Third Trimester of Pregnancy.
Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis.
FDA approval announcement for ofatumumab
Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice.
Serum from interferon-β-1b-treated patients with early multiple sclerosis stabilizes the blood-brain barrier in vitro.
Biogen Third Quarter 2015 Revenues Increase 11% to $2.8 Billion; Company Raises 2015 Full Year Guidance
A genetic screen identifies genes essential for development of myelinated axons in zebrafish.
Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators.
The immunopathology of multiple sclerosis: an overview.
Selective inhibition of the mitochondrial permeability transition pore protects against neuro-degeneration in experimental multiple sclerosis.
Impact of MS during the critical window of brain development.
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study.
The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.
Lithium Controls Central Nervous System Autoimmunity through Modulation of IFN-γ Signaling.
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration.
Fingolimod Impedes Schwann Cell-Mediated Myelination: Implications for the Treatment of Immune Neuropathies?Effect of Fingolimod on Schwann Cells.
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial.
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder.
A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.
Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis.
Interferon-beta in pediatric multiple sclerosis patients: safety in short-term prescription.
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis.
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS.

Pages